Anavex Life Sciences Corp (AVXL)

[falconer66a]

The Article Will Be Anavex's Real Start

...it is clear Missing is waiting to release the full data in a detailed scientific publication, that
covers ten years of clinical results Including:....

Well, how would things be different if this were the case, that Missling and company are in the long process of getting assembled and written a comprehensive, definitive peer-reviewed journal article that presents all of blarcamesine's clinical data; including all of the presently-contentious missing data? What if the n number of the Alzheimer's study actually produced statistically significant improvements in Alzheimer's symptoms, perhaps even reversing them?

If such a paper appears in a recognized journal, everything for Anavex changes. Of course, the usual Anavex naysayers will continue to present all of their oft-repeated arguments that Missling is incompetent, that a plethora of new clinical trials will be required, etc. When blarcamesine gets approved for therapeutic uses anywhere in the world, these helpful people will be telling us that that was an error, and the drug simply won't work as either a treatment or prophylaxis for any CNS condition.

But after the peer-reviewed article appears, substantiating blarcamesine's safety and efficacy, everything changes. The FDA will be under intense public pressure to promptly approve the drug. Big Pharmas will realize that Anavex, with blarcamesine for sale, will be a major competitor, capturing the global market for Alzheimer's treatment. Billions upon billions of dollars of revenues. With their MABs, do they try to compete, or try to buy out Anavex?

With its substantiating, comprehensive data, a peer-reviewed journal article updating what is clinically proven about blarcamesine's safety and efficacies will be the effective start of Anavex Life Sciences Corp as a global pharmaceutical.